A new therapy for the treatment of myeloproliferative diseases

  • The present invention describes the neural mechanisms regulating the haematopoietic niche, regulatory mechanisms that are impaired in myeloproliferative neoplasms (MPN) and that contribute to the disease´s pathogenesis, thereby emerging as new therapeutic targets.

    Number
    P201330677
    Priority date
    Applicants
    CNIC
    Inventors
    Simón Méndez Ferrer, Lorena Arranz Salas, Joan Isern Marín